Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Inflammx Therapeutics Inc, explained in plain language.
This completed Phase 2 study tested whether the oral drug Xiflam (tonabersat) can safely reduce symptoms of Long COVID compared to a placebo. Sixteen adults who had COVID-19 and then developed lasting symptoms for at least 12 weeks took part. Participants received either Xiflam o…
Phase: PHASE2 • Sponsor: Inflammx Therapeutics Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC